GlassScriptPhysician profile
Kenneth P Kaiser
NPI 1073557039
$11,121.32
in general payments reported to CMS, 2019-2025
51 companies · $1,232 in 2025
The $1,232 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,459 · 2022: $2,296 · 2023: $2,400 · 2024: $1,734 · 2025: $1,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,366.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,448.74 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,334.99 | 2021-2025 | |
| Lilly USA, LLC | $947.64 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $761.87 | 2021-2024 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $593.04 | 2021-2025 | Evenity, Prolia, Repatha |
| Axsome Therapeutics, INC. | $483.65 | 2022-2025 | Sunosi, Auvelity |
| Pfizer INC. | $479.58 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $475.98 | 2021-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $401.57 | 2021-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.47 | 2021-2023 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $306.18 | 2021-2024 | |
| Radius Health, INC. | $298.93 | 2021-2025 | |
| Ironwood Pharmaceuticals, INC | $282.49 | 2021-2024 | Linzess |
| Corcept Therapeutics | $230.08 | 2021-2025 | Korlym |
| Esperion Therapeutics, INC. | $224.25 | 2021-2025 | Nexletol |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $208.15 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $200.00 | 2021-2023 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $167.80 | 2021-2022 | |
| Amarin Pharma, INC. | $162.07 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $132.40 | 2021 | |
| Jazz Pharmaceuticals INC. | $129.47 | 2021-2022 | |
| Astellas Pharma US INC | $116.47 | 2021-2025 | Veozah |
| Daiichi Sankyo INC. | $107.49 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $90.95 | 2022 | |
| Shield Therapeutics INC | $90.83 | 2022-2025 | Accrufer |
| Glaxosmithkline, LLC. | $83.42 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $82.89 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $76.54 | 2023-2025 | Gemtesa |
| Abbott Laboratories | $71.38 | 2021-2023 | Freestyle Libre 3 |
| Exact Sciences Corporation | $64.93 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sunovion Pharmaceuticals INC. | $63.06 | 2021-2022 | |
| Harmony Biosciences LLC | $53.34 | 2023 | Wakix |
| Otsuka America Pharmaceutical, INC. | $50.92 | 2024 | Rexulti |
| Phathom Pharmaceuticals, INC. | $50.15 | 2024-2025 | Voquezna |
| Hikma Pharmaceuticals USA | $45.31 | 2022 | |
| Dexcom, INC. | $42.14 | 2021-2023 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $40.86 | 2021-2022 | |
| Inspire Medical Systems, INC. | $39.39 | 2024-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $37.13 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $35.49 | 2023 | Contrave, Onzetra Xsail, Nexlizet |
| Medtronic, INC. | $33.77 | 2023-2024 | Minimed 780g, Intellis Adaptivestim |
| Lundbeck LLC | $25.10 | 2025 | Vyepti |
| Merck Sharp & Dohme LLC | $24.05 | 2021 | |
| Ascensia Diabetes Care US INC. | $23.42 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $23.00 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.87 | 2021 | |
| Verona Pharma, INC. | $21.49 | 2025 | Ohtuvayre |
| Eisai INC. | $18.70 | 2021 | |
| Xeris Pharmaceuticals, INC. | $18.64 | 2023 | Gvoke Hypopen |
| Ardelyx, INC. | $17.41 | 2024 | Ibsrela |
| Averitas Pharma INC. | $15.83 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.